Cervical Cancer Screening Project
Cervical cancer is the second most common cancer (after breast cancer) in women in the less developed countries with an estimated 445,000 new cases in 2012. Approximately 270,000 of women die from cervical cancer annually; more than 85% of these deaths occurring in low and middle income countries. The main cause of cervical cancer is high risk Human Papilloma (HPV) viral infection, particularly HPV-16 and 18 subtypes which cause 70% of cervical cancer and precancerous lesions. Most HPV related lesions resolve spontaneously, but there is a high risk for persistent lesions (cervical dysplasia) to progress to invasive cervical cancer in 5 – 20 years if misdiagnosed and/or untreated. The high death rate from cervical cancer globally (52%) could be reduced by effective screening and treatment programs (WHO Factsheet, http://www.who.int/mediacentre/factsheets/fs380/en/).
There is no accurate data on the prevalence of cervical cancer in Sudan. Moreover, Sudan is lacking a national screening program. Additionally there is a high demand for training in colposcopy and related surgical procedures for cervical dysplasia detection and early intervention before progression to invasive cancer. The Sudanese American Medical Association (SAMA) has established a training center in collaboration with Soba University Hospital and other partners for training in the management of cervical dysplasia and prevention of cervical cancer in Sudan.
- Train OB/GYN physicians in colposcopy and early detection of pre-cancerous lesions.
- Train physicians on surgical interventions to treat cervical dysplasia before it progresses into invasive cancer.
- Exchange expertise in the field to contribute to cervical cancer prevention.
- Raising the awareness in the community and amongst women-health personnel about the disease.
- Provision of equipment for training of Obs/Gyn physicians in cervical dysplasia.